We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary |  ONLINE FIRST
Wayne L. Hofstetter, MD
JAMA Surg. Published online November 11, 2015. doi:10.1001/jamasurg.2015.4047

Original Investigation |  ONLINE FIRST
Emmanuel Gabriel, MD, PhD; Kristopher Attwood, PhD; William Du, MD; et al.
JAMA Surg. Published online November 11, 2015. doi:10.1001/jamasurg.2015.4068
Includes: Supplemental Content

Surgical Innovation |  ONLINE FIRST
Zaynab Jawad, MSc, MRCS; Fang Xie, PhD; Long R. Jiao, MD, FRCS
JAMA Surg. Published online October 07, 2015. doi:10.1001/jamasurg.2015.2654

Invited Commentary | 
Mu Xu, MD, PhD; O. Joe Hines, MD
JAMA Surg. 2015;150(8):710-711. doi:10.1001/jamasurg.2015.0702.

Original Investigation | 
Alessandro Paniccia, MD; Patrick Hosokawa, MS; William Henderson, PhD; et al.
JAMA Surg. 2015;150(8):701-710. doi:10.1001/jamasurg.2015.0668.
Includes: CME, Supplemental Content

Invited Commentary | 
David H. Berger, MD, MHCM
JAMA Surg. 2014;149(5):457-458. doi:10.1001/jamasurg.2013.4163.

Original Investigation |  FREE
Ramesh B. Batchu, PhD; Oksana Gruzdyn, BS; Ravindra B. Potti, PhD; et al.
JAMA Surg. 2014;149(5):451-457. doi:10.1001/jamasurg.2013.4113.

Invited Critique | 
Ronan Cahill, MD
JAMA Surg. 2013;148(3):231. doi:10.1001/jamasurg.2013.703.

Invited Critique | 
Steven D. Colquhoun, MD
Arch Surg. 2012;147(11):1061. doi:10.1001/jamasurg.2013.493.

Review Article |  FREE
Kevin P. Charpentier, MD
Arch Surg. 2012;147(11):1053-1061. doi:10.1001/2013.jamasurg.100.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Observation  | 
Complete Remission of Squamous Cell Carcinoma After Treatment With Panitumumab in a Patient With Cetuximab-Induced Anaphylaxis
Aurélie Marti, MS; Antoine Fauconneau, MD; Nora Ouhabrache, MD; et al.
JAMA Dermatology
Viewpoint  | 
Innovative New Drugs for Serious Nonlethal Diseases The Cost to Develop and the Cost to Buy
William H. Eaglstein, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
JAMA Oncology
From The JAMA Network  | 
Surrogates for Survival or Other End Points in Oncology
Michael LeBlanc, PhD; Catherine Tangen, DrPH